Dr.
Shrikant Verma is an accomplished academician, researcher, author, and
scientific editor specializing in Personalized & Molecular Medicine,
Molecular Biology, Human Genetics, Pharmacogenomics, Infectious Diseases, and
Precision Medicine. He currently serves as an Assistant Professor in the
Department of Personalized & Molecular Medicine at Era University, Lucknow,
India, where he contributes to teaching, research, postgraduate training, and
translational healthcare initiatives. With extensive research experience, Dr.
Verma has developed a multidisciplinary research portfolio spanning
pharmacogenomics, cardiovascular genetics, heart failure, COVID-19 and biomarker
discovery. His research emphasizes translating molecular and genomic
discoveries into clinically meaningful approaches for early disease prediction,
risk stratification, treatment optimization, and individualized patient care.
He has been involved as a Principal Investigator/Co-Principal Investigator in
institutional and externally supported research projects. Dr. Verma has an
extensive scholarly record, with 56 publications, 26 edited books, and 3 authored
books, reflecting his sustained contribution to scientific literature and
academic knowledge dissemination. His work has also extended into emerging
areas including precision cardiovascular diagnostics, molecular prediction of
heart-failure progression, pharmacogenomic determinants of therapeutic
response, and personalized nutrition. Beyond research and teaching, Dr. Verma
actively contributes to the international scholarly community through editorial
and peer-review responsibilities with journals and academic publishing
organizations, including roles as Scientific Editor, Academic Editor, and
Editorial Board Member. He is also associated with several national and
international professional societies in personalized medicine, cardiovascular
genomics, molecular genetics, and related disciplines. Through his integrated
focus on research, education, scientific publishing, and translational
medicine, Dr. Verma is committed to advancing precision healthcare and
strengthening the connection between laboratory discoveries and bedside
applications.
Editorial Board Member
Dr. Shrikant Verma
Research Interests :
Introduction
AFFILIATION
Assistant Professor
Department of Personalized and Molecular Medicine
Era University
Tondan Marg, Sarfarazganj
Lucknow
India
226003
Email : shrikant.verma@erauniversity.in
RESEARCH IDS
| # | ID Type |
|---|---|
| 1. | Google Scholar |
| 2. | Research Gate |
| 3. | ORCiD |
| 4. | SCOPUS |
| 5. | Web of Science |
RESEARCH INTERESTS
| # | Area |
|---|---|
| 1. | Cardiovascular Genomics |
| 2. | Human Genetics |
| 3. | Molecular Biology |
| 4. | Personalized Medicine |
| 5. | Precision Medicine |
PAPERS PUBLISHED
| # | Article Title | Year |
|---|---|---|
| 1. | S. Verma, S. Verma, M. Abbas, T. Faruqui, B. A. Mir, and F. Mahdi, “Genetic Biomarkers in the Risk Assessment of Sudden Cardiac Events: A Personalized Approach,” iNew Medicine (2026): e70060, https://doi.org/10.1002/inm3.70060. | 2026 |
| 2. | Verma S, Verma S, Mir BA, Tabrez Faruqui, Abbas M, Mahdi F. Risk Stratification and Prevention of Sudden Cardiac Death: Bridging Structural and Electrical Etiologies. Era J Med Res. 2026;13(1):57-63 | 2026 |
| 3. | Verma S, Verma S, Faruqui T, Abbas M, Mahdi F. Risk Stratification and Prevention of Sudden Cardiac Death: Bridging Structural and Electrical Etiologies. Era J. Med. Res. 2026 | 2026 |
| 4. | Mehdi M, Verma S, Mir BA, Verma S, Rizvi AA, Ansari AI, Abbas M, Mahdi F. Precision Medicine in Cardiomyopathy: Advances and Future Directions. Clin Genet. 2025 Dec;108(6):641-653 | 2025 |
| 5. | Verma S, Verma S, Siddiqi Z, Raza ST, Faruqui T, Ansari AI, Abbas M, Mahdi F. Association of VDR and TMPRSS2 gene polymorphisms with COVID-19 severity: a computational and clinical study. Mol Biol Rep. 2025 Mar 19;52(1):327. https://doi.org/10.1007/s11033-025-10417-2 (First Author) | 2025 |
| 6. | Verma S, Verma S, Afreen S, Siddiqi Z, Khan FH, Abbas M, Mahdi F. Impact of interleukin-1 gene polymorphisms on the severity of COVID-19. Human Gene. 2024 Jun 13:201303. (First author) | 2024 |
| 7. | Verma S, Verma S, Khan FH, Siddiqi Z, Raza ST, Abbas M, Mahdi F. Genetic polymorphisms of IL6 gene–174G> C and–597G> A are associated with the risk of COVID-19 severity. International Journal of Immunogenetics. 2023 Feb; 50(1):5-11. (First Author) | 2023 |
| 8. | Khan A, Abbas M, Verma S, Verma S, Rizvi AA, Haider F, Raza ST, Mahdi F. Genetic Variants and Drug Efficacy in Tuberculosis: A Step toward Personalized Therapy. Global Medical Genetics. 2022 (Co-author) | 2022 |
| 9. | Abbas M, Verma S, Verma S, Siddiqui S, Khan FH, Raza ST, Siddiqi Z, Eba A, Mahdi F. Association of GSTM1 and GSTT1 gene polymorphisms with COVID-19 susceptibility and its outcome. Journal of medical virology. 2021 ;93(9):5446-5451. (Co-author) | 2021 |
| 10. | Verma S, Abbas M, Verma S, Khan FH, Raza ST, Siddiqi Z, Ahmad I, Mahdi F. Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients. Infection, Genetics and Evolution. 2021 Jul 1; 91:104801. (Co-author) | 2021 |
BOOKS PUBLISHED
| # | Title | Publication Year |
|---|
BOOK CHAPTERS PUBLISHED
| # | Chapter Title | Book Title | Publication Year |
|---|
ACADEMIC PROFILE
| # | Examination | Passing Year | Country |
|---|---|---|---|
| 1. | Ph.D. (Biotechnology) | 2025 | India |
| 2. | M.Sc. (Microbiology) | 2019 | India |
| 3. | B.Sc. (Zoology, Chemistry | 2015 | India |
EMPLOYMENT DETAILS
| # | Institution | Position | Country | Service Period |
|---|---|---|---|---|
| 1. | Era University | Assistant Professor | India | 1 years, 4 months, 20 days |
| 2. | Era University | Research Assistant | India | 4 years, 3 months, 0 days |
| Total Period : | 5 years, 7 months, 20 days |
PAPERS PRESENTED IN CONFERENCES
RESEARCH PROJECTS
MEMBERSHIPS
TRAINING PROGRAMS ATTENDED
HONOURS AWARDS AND DISTINCTIONS
EVENTS ATTENDED
EVENTS ORGANIZED